Healthcare ❯ Pharmaceuticals ❯ Drug Pricing

Medicare

Negotiations Medicaid Negotiation Negotiation Programs Weight Loss Drugs Inflation Reduction Act Coverage Policies Obesity Health Policy Price Reductions GLP-1 Drugs Cost Reduction Price Negotiation Cost Savings Negotiation Policies International Pricing Models Legal Challenges Cost of Healthcare Health Insurance Policy Impact

Supreme Court Rejects Drugmakers’ Appeals Over Medicare Price Talks

The move preserves rulings that back the Inflation Reduction Act program, letting new rounds of negotiated discounts proceed.

CMS Names 15 Drugs for 2028 Medicare Price Talks, First List to Include Part B Treatments

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2026 Mina Labs Inc.